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Leptin decreases food intake and increases energy expenditure. Leptin administration into
the CNS of mice or rats increases alveolar ventilation and dysfunction in leptin signaling
has been implicated in the hypoventilation that can accompany obesity. An increase in
CO2 chemosensitivity has been implicated in this response but it is unclear whether
ventilation is augmented when PCO2 is maintained constant. We examined the effects of
intravenous leptin to test the hypothesis that systemic leptin administration in isoflurane
anesthetized, mechanically ventilated and vagotomized rats would lead to a sustained
increase in respiratory motor output that was independent of changes in end-tidal PCO2,
body temperature or lung inflation pressure (an indicator of overall lung and chest wall
compliance). In anesthetized Sprague-Dawley rats with end-tidal PCO2, lung compliance
and rectal temperature maintained constant, injection of a bolus of leptin (0.25mg,
0.5mg/ml, i.v.), followed over the next 1 h by the intravenous infusion of an additional
0.25mg, elicited a progressive increase in the peak amplitude of integrated phrenic nerve
discharge lasting at least 1 h beyond the end of the infusion. The increase peaked at 90min
at 58.3 ± 5.7% above baseline. There was an associated increase in the slope of the
phrenic response to increasing inspired CO2. There was also a moderate and sustained
decrease in arterial pressure 9 ± 1.3mmHg at 120min, with no associated change in heart
rate. These data indicate that leptin elicits a sustained increase in respiratory motor output
that outlasts the administration leptin via a mechanism that does not require alterations in
arterial PCO2, body temperature, or systemic afferent feedback via the vagus nerves. This
stimulation may help to prevent obesity-related hypoventilation.
Keywords: leptin stimulation of breathing, neural control of breathing, metabolic control of breathing, leptin,
respiratory modulation
INTRODUCTION
The cytokine, leptin, is an anorexogenic hormone that plays
an important role in the regulation of energy balance.
Administration of leptin reduces eating and increases energy
expenditure (Cone, 2005; Myers et al., 2008; Cammisotto et al.,
2010) largely through a sympathetically mediated increase in
brown adipose thermogenesis (Morrison, 2004) and through an
increase in spontaneous physical activity (Choi et al., 2008).
Adipocytes are amajor source of leptin and obese humans have
substantially elevated circulating leptin levels, consistent with
their high percentage of body fat. The increasedmetabolic activity
associated with obesity increases CO2 production, necessitating a
corresponding increase in alveolar ventilation to maintain home-
ostasis of arterial PCO2 (PaCO2) and acid-base status. A subset
of obese individuals hypoventilate with substantial elevations in
PaCO2 in a condition termed obesity hypoventilation syndrome
(Zwillich et al., 1975; Mokhlesi et al., 2008; Mokhlesi, 2010;
Piper and Grunstein, 2011). The failure of the high leptin lev-
els to suppress appetite and increase energy expenditure in these
obese individuals is generally attributed to a resistance to leptin
(Myers et al., 2008; Al Dabal and BaHammam, 2009).
Studies in mice are consistent with the concept that lep-
tin is an important contributor in the normal linkage between
metabolism and alveolar ventilation in obesity. For example, adult
ob/ob mice have a mutation in the gene for leptin and lack
functional leptin, are markedly obese and hypoventilate with
consequent marked increases in PaCO2 (PaCO2 > 45mmHg).
Associated with the hypoventilation is a decrease in chemosen-
sitivity as indicated by a reduction in the slope of the relation-
ship between minute ventilation and PaCO2 (O’Donnell et al.,
1999). Administration of leptin either intravenously or into the
cerebral ventricles of these mice restores chemosensitivity and
normocapnia (O’Donnell et al., 1999; Bassi et al., 2012).
The potential role of leptin in respiratory control has also
been examined in rats, but the outcome is less clear. Obese
Zucker or Koletsky rats with mutations in the receptor for lep-
tin exhibit abnormal breathing patterns (Farkas and Schlenker,
1994; Strohl and Thomas, 2001), but a heritability analysis of the
breathing pattern abnormalities in Zucker rats only attributed
a minor role to the leptin receptor (Iyengar et al., 2004).
Nevertheless, injections of leptin directly into the nucleus of
the solitary tract (NTS) produce a substantial, dose-dependent
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stimulation of breathing, primarily through an increase in the
magnitude of phrenic nerve bursts, the neural equivalent of
tidal volume (Inyushkin et al., 2009; Inyushkina et al., 2010).
The reasons are not clear for this apparent discrepancy in the
linkage between leptin and alveolar ventilation. One possibility
is that obese Zucker and Koletsky rats develop compensatory
changes in respiratory control that make them less dependent
on leptin for respiratory homeostasis. Additionally, a number
of factors are difficult to control for, such as the impact of
obesity on pulmonary mechanics, metabolism, and thermoregu-
lation and on the regulation of arterial blood gases and acid-base
balance.
The current study was designed to test the hypothesis that
systemic leptin administration in rats would lead to a sus-
tained increase in respiratory motor output that was inde-
pendent of leptin-induced changes in CO2 production, body
temperature or overall lung mechanics. The findings support
the concept that when end-tidal PCO2, body temperature,
and overall lung mechanics are maintained within narrow
limits, intravenous leptin administration produces a time-
dependent and sustained increase in respiratory motor output
that outlasts the period of leptin administration by at least
60min.
MATERIALS AND METHODS
ANIMALS
Experiments were performed on adult male Sprague-Dawley rats
(Charles River, Wilmington, MA, USA) weighing 300–500 g. All
surgeries were performed using sterile procedures adapted for
small rodents, in accordance with guidelines recommended by
the NIH and by the Society for Neuroscience. The Northwestern
University Animal Care and Use Committee approved all
procedures.
SURGERY
Anesthesia was induced with 5% isoflurane (in 50% O2, bal-
ance N2) in an induction chamber. Animals were then rapidly
switched from the induction chamber to a nose cone attached
to a stereotaxic frame where the animal was allowed to freely
breathe isoflurane (2.5–3%) for maintenance. The depth of anes-
thesia was frequently assessed (10–15min intervals) and judged
by the absence of retraction responses to a strong noxious paw
pinch, and by the absence of changes in heart rate or breathing
pattern in response to the noxious stimulation. Rectal tempera-
ture was monitored and maintained at 37.5 ± 0.5◦C by means
of a thermistor-controlled heat lamp. The ECG was continu-
ously monitored using transcutaneous needle electrodes placed
on the caudal thorax with a ground wire placed laterally on
the abdomen. These electrodes also recorded diaphragm EMG
prior to paralyzing the animals (see below). Oxygen satura-
tion as well as heart rate and respiratory rate were monitored
via a pulse oximeter (Mouse Ox, Starr Life Sciences, Oakmont,
PA, USA).
Vagi were sectioned bilaterally in the neck. The trachea was
cannulated high in the neck and rats were mechanically venti-
lated (2.0–2.5ml, ∼70min−1) and airway pressure was contin-
uously monitored. End-tidal PCO2 was continuously sampled
at the mouth using a rapidly responding infrared CO2 monitor
(Puritan–Bennett Co., Datex 223) modified to minimize the dead
space volume. The tidal volume was increased for 2–3 breaths
every 10–15min to prevent atelectasis.
With these ventilator settings, baseline ventilation was suffi-
cient to lower PCO2 below the apneic threshold and CO2 was
added to the inspired port of the ventilator to raise the end-
tidal PCO2 3–5mmHg above the apneic threshold. The level
of inspired CO2 was then continuously adjusted to maintain
end-tidal PCO2 within 1mmHg of this initial level. Since the
administration of leptin increases brown adipose thermogene-
sis and hence PCO2 (Morrison, 2004), for rats receiving leptin
the level of inspired CO2 was decreased to maintain a constant
end-tidal PCO2.
The left femoral artery was cannulated (PE-50) for record-
ing arterial pressure. The femoral veins were cannulated (PE-10)
bilaterally. One vein was used for infusion of fluids (lactated
Ringer’s, 3–8ml/h) and administration of a paralytic, either
pancuronium bromide (1mg/kg/h) or succinyl choline chloride
(5mg/kg/h). The contralateral vein was used for infusion of
leptin.
Animals were placed in a stereotaxic frame and a phrenic nerve
was exposed in the neck, cleaned of connective tissue, placed on
a bipolar silver hook recording electrode and immersed in min-
eral oil to prevent drying. Nerve activity was amplified (bandpass
filtered, 0.3–3 kHz), digitized at 10 kHz and recorded on a labo-
ratory computer using Spike 2 software (CED Ltd., Cambridge,
England).
EXPERIMENTAL PROTOCOL
At least 1 h following surgery, baseline levels of integrated phrenic
nerve activity, arterial pressure, heart rate, end-tidal PCO2, airway
pressure, and rectal temperature were recorded for 10–30min.
Leptin was dissolved in lactated Ringer’s solution and adminis-
tered using a protocol similar to that reported by Haynes et al.
(1997) with the total dose being within the range that has previ-
ously been shown to induce Fos-immunoreactivity in the CNS of
adult rats (Elias et al., 2000). Separate groups of rats received lep-
tin (n = 6) or lactated Ringer’s solution (n = 4) intravenously. In
the leptin group, an initial bolus of leptin (0.25mg, 0.5mg/ml)
was administered, followed by the continuous intravenous infu-
sion of an additional 0.25mg over the following 60min. The
control group received lactated Ringer’s (the leptin vehicle) deliv-
ered as a 0.5ml bolus and subsequent 0.5ml infusion over a
1 h period. Phrenic nerve activity, arterial pressure, heart rate,
end-tidal PCO2, rectal temperature, and airway pressure were
continuously monitored during the pre-injection control and
for an additional 1 h following the termination of the infu-
sion. At the end of this recording period, a CO2 response curve
was generated by increasing the fraction of CO2 in the inspired
gas. CO2 was elevated in two steps; the first was 20–30mmHg
above baseline while the 2nd raised end-tidal PCO2 to about
100mmHg. Each step was maintained for about 4min with
quasi steady-state measurements made during the last 30 s of
each step.
Rats were then sacrificed by increasing the inspired isoflurane
to 5% followed by a bilateral pneumothorax or decapitation.
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DATA ANALYSIS
Data obtained during control measurements and for the 2 h test
of the effect of leptin administration were analyzed using a nested
analysis of variance model with group as the between-rat factor
and time as the within rat factor. The group by time interac-
tion term was also tested. Post-hoc comparisons were made using
Bonferroni-corrected t-tests.
Slopes of the CO2 response curves for each rat were calculated
using a least squares regression through the three levels of CO2.
Slopes for leptin treated vs. control rats were then compared using
a one-tailed T-test.
The possible correlation between any change in phrenic nerve
activity and a corresponding change in arterial pressure was deter-
mined using a Spearman’s rank correlation coefficient. Values
of phrenic nerve discharge and mean arterial pressure (MAP)
during control and at 15min intervals for 2 h after the initial
administration of leptin were compared.
RESULTS
Intravenous administration ofmurine leptin to anesthetized adult
rats (n = 6) elicited a sustained increase in phrenic nerve dis-
charge and a modest decrease in arterial pressure. Over the course
of an experiment, homeostatic parameters that could influence
either gas exchange or cardiorespiratory control were main-
tained within narrow limits for both leptin and control groups
of animals. Specifically, no significant changes were recorded in
end-tidal PCO2, rectal temperature (Figure 1, Table 1), or air-
way pressure (not shown) over the recording period. Although
there was an initial difference in PCO2 between the groups, the
PCO2 of individual animals was maintained within 1mmHg of
its starting value and therefore did not significantly contribute
to the progressive increase in phrenic nerve discharge seen in
the leptin group (see below). At the beginning of each exper-
iment the ventilator was set at a tidal volume of ∼2.5ml and
70 cycles/min. For both groups CO2 was added to the inspired
gas mixture to bring the end-tidal PCO2 to 3–5mmHg above the
apneic threshold.
RESPIRATORYMOTOR RESPONSES TO INTRAVENOUS LEPTIN
Injection of a bolus of leptin (250µg, i.v.), followed over the next
hour by the intravenous infusion of an additional 250µg, elicited
a progressive increase in phrenic nerve discharge (Figures 1A, 2;
n = 5 − 6; p < 0.05) lasting at least 1 h beyond the end of the
infusion. In contrast, intravenous injection of the vehicle (lactated
Ringer’s containing phosphate buffered saline; Figures 1B, 2;
n = 2 − 4) elicited no significant change in respiratory motor
output.
The increase in phrenic nerve discharge in leptin treated rats
was primarily seen as an increase in the peak amplitude of
the integrated phrenic nerve discharge (Figure 2). The increase
began within 15min of the initial leptin injection and was sig-
nificant at 60min following the initial injection, at which time
the increase averaged 39.2 ± 9.3% above baseline. The increase
peaked at 90min (i.e., 30min after terminating the leptin infu-
sion) when it averaged 58.3 ± 5.7% above baseline. One hour
after terminating the leptin infusion, the peak amplitude of inte-
grated phrenic nerve activity was still elevated 47.5 ± 6.7% above
baseline. The neural equivalent of minute ventilation (phrenic
burst frequency x peak amplitude of each phrenic burst) was also
significantly increased from baseline at 75, 90, and 120min after
the initiation of the leptin injection (not shown), although there
was no significant change in the phrenic nerve burst frequency
(Figures 1A, 2).
To test the aggregate sensitivity of central and peripheral
chemoreceptors, a CO2 response curve was generated at the end
of the experiment in both the leptin and control groups of ani-
mals. The average slope of the CO2 response curve in leptin
treated rats (Figure 3; n = 7) was more than twice that of control
animals (P < 0.05; n = 4).
CARDIOVASCULAR RESPONSES TO INTRAVENOUS LEPTIN
Leptin treatment elicited a progressive decrease in MAP over
the 120min following the initiation of leptin administration.
At 120min, MAP had decreased 10 ± 1.3mmHg from a con-
trol of 79 ± 4.1mmHg (Figures 1, 4; p < 0.05). Both systolic
and diastolic pressures exhibited similar decreases. There was
no significant change in MAP of control animals; compared to
an initial value of 86 ± 4.3mmHg, MAP was 84 ± 4.9mmHg at
90min, (n = 4) and in the two rats measured at 120min it was
87 ± 1.0mmHg (Figures 1, 4). Despite the decrease in MAP in
leptin treated rats, there was no change in heart rate over the
course of the experiment in either the leptin or control group of
animals (Figures 1, 4).
CORRELATION BETWEEN THE INCREASE IN PHRENIC DISCHARGE AND
DECREASE IN MEAN ARTERIAL PRESSURE
The Spearman’s rank correlation coefficient revealed a signifi-
cant correlation between the increase in phrenic discharge and
decrease in MAP (−0.8833, P < 0.05). While the decrease in
MAP could contribute to the increase in phrenic discharge, the
decrease was relatively small, averaging 10 ± 1.3mmHg. At the
end of the experiment, the MAP was still 69 ± 4.8mmHg in
leptin-treated rats. This is still above the value generally taken as
the lower limit for autoregulation (e.g., cerebral autoregulatory
range: 60–150mmHg; Paulson et al., 1990). Thus, a significant
decrease in organ perfusion, including the brain, would not be
anticipated. Further, equivalent decreases in MAP induced with
i.v. sodium nitroprusside in a separate group of rats did not elicit
significant increases in phrenic burst amplitude (not shown).
Perhaps more importantly, is the progressive nature of the
changes in both MAP and phrenic burst amplitude. For instance,
if there was a causal relationship, the small decreases in MAP
at 30min (−1.5 ± 0.7mmHg) and 60min (−3.7 ± 0.5mmHg)
would have been responsible for 31.7 ± 10.0% and 39.4 ± 8.2%
increases in phrenic nerve discharge, respectively. Thus, although
a contribution of the decrease in arterial pressure to the increase
in the increase in phrenic nerve discharge cannot be completely
ruled out, a direct effect of leptin on central respiratory control
seems likely to be more important.
DISCUSSION
The major finding of the current investigation was that sys-
temic leptin infusion causes a progressive and sustained increase
in respiratory motor output in isoflurane-anesthetized rats.
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FIGURE 1 | Example of the time course of the increase in phrenic nerve
activity (
∫
Phr) and decrease in arterial pressure (AP) in response to
intravenous leptin. (A) 250µg leptin bolus at beginning of the bar indicating
leptin injection, followed by 250µg infused over the indicated period.
(B) Control response to injection of the vehicle for leptin (lactated Ringer’s).
Dots above AP trace in (A) indicate flush of the arterial line. Dots above
end-tidal CO2 trace (ETCO2) indicate artifacts arising from augmented
inflations to prevent atelectasis. a.u., arbitrary units; AP, arterial pressure;
ETCO2, end-tidal carbon dioxide; HR, heart rate;
∫
Phr, integrated phrenic
nerve activity; RR, respiratory rate; TR, rectal temperature.
The average peak amplitude of integrated phrenic nerve bursts
increased to almost 160% of baseline 90min following the ini-
tiation of an intravenous leptin infusion. There was little or no
associated change in the phrenic nerve burst frequency. There was
also a moderate and sustained decrease in arterial pressure, with
no associated change in heart rate.
CRITIQUE OF METHODS
An important consideration in the interpretation of the cur-
rent data is whether PaCO2 was constant throughout the test
period. A systematic elevation in PaCO2 over the course exper-
iment could compromise the data interpretation. In the current
study, end-tidal PCO2 was used to estimate PaCO2. Several steps
were taken to optimize the measurement of end-tidal PCO2.
First, we minimized the dead space of the CO2 monitor and the
associated sampling line. To reduce the impact of changing ven-
tilator settings on the CO2 sampling, we used a relatively large
tidal volume (∼2.5ml). To permit fine tuning of the end-tidal
PCO2 throughout the experiment, the ventilator frequency was
increased, prior to beginning leptin administration, sufficiently
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to lower PCO2 several mmHg below the apneic threshold. The
FICO2 was then increased to raise PCO2 3–5mmHg above the
apneic threshold. Once the ventilator volume and frequency were
set at the beginning of the experiment they were not adjusted
throughout the remainder of the experiment. This prevented any
change in ventilator settings from influencing the end-tidal PCO2
measurement. Any adjustment necessary to maintain a constant
end-tidal PCO2 was accomplished by fine tuning the FICO2.
To prevent atelectasis, the rats are “sighed” every 10–15min
(e.g., see Figure 1). We also continuously recorded airway pres-
sure to ensure that there were no overall changes in lung mechan-
ics. During control, the inflation pressure for the six leptin treated
animals was 7.6 ± 0.5 cmH2O (n = 6). At the end of the exper-
iment (2 h after beginning leptin infusion) airway pressure was
7.9 ± 0.5 cmH2O (P = 0.6). In addition, pulse oximetry indi-
cated that O2 saturation remained above 95%, suggesting that
gas exchange was not impaired over the course of the experi-
ment. Thus, while it is possible that there was a slight difference
between our measured end-tidal PCO2 and PaCO2, we believe
any such difference was small. More importantly, any difference
between end-tidal PCO2 and PaCO2 should have been constant
throughout the experiment. Hence, we believe that PaCO2 was
maintained within 1mmHg of the starting value throughout the
experiment.
EFFECT OF SYSTEMIC LEPTIN INFUSION ON PHRENIC NERVE ACTIVITY
Our observation of a leptin-induced increase in phrenic nerve
activity in the rat is consistent with earlier work in mice. Mice
with a mutation in the ob gene do not have leptin, are obese and
hypoventilate in all sleep-wake states (O’Donnell et al., 1999).
During wakefulness, the hypoventilation can be substantial with
PaCO2 exceeding that of a control group by more than 10mmHg
(O’Donnell et al., 1999). Replacement therapy by systemic leptin
infusion increased minute ventilation as well as the ventilatory
response to an inhaled CO2 challenge (O’Donnell et al., 1999).
The increase in the CO2 response of ob/ob mice in response
to intracerebroventricular leptin administration strongly argues
that at least a component of this response is centrally mediated
(Bassi et al., 2012).
The current findings extend this work by directly showing
that systemic leptin administration increases respiratory motor
output. The underlying mechanism(s) remain to be resolved.
O’Donnell et al. (1999) argued that leptin was acting at a CNS site
since an increase in metabolism did not appear to be account for
the stimulation. However, the metabolic changes in their experi-
ments were complex as the rate of oxygen consumption increased
in leptin treated mice although there was no change in carbon
dioxide production. This resulted in a decrease in the respira-
tory exchange ratio from 0.81 ± 0.02 to 0.63 ± 0.02. The current
findings extend this earlier work by establishing that the increase
in respiratory motor output occurs even when metabolic fac-
tors such as PCO2 and body temperature are closely controlled
(Table 1). In the current study, leptin-induced changes in end-
tidal PCO2 were prevented by continuously adjusting the CO2
level in the inspired gas (see “Materials and Methods”).
The current findings are also consistent with previous work
showing that microinjection of leptin into the NTS produces a
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FIGURE 2 | Integrated phrenic nerve amplitude (
∫
Phr normalized to
baseline) and burst frequency (Resp Freq) at baseline (0min) and at
15min intervals for the experiment in Figure 1 (leptin; n = 6 except as
indicated on graph; control, lactated Ringer’s; n = 4 except as
indicated). Note the selective increase in
∫
Phrenic in leptin treated rats,
∗p < 0.05.
FIGURE 3 | CO2 Response curves in leptin (n = 7) vs. control (n = 4)
rats measured 2–2.5h following the initial bolus injection of leptin.
Three levels of CO2 were delivered via altering the fraction of CO2 in
the inspired gas delivered via the ventilator. (A) Plot of the average
phrenic nerve activity at each level of end-tidal PCO2. Responses were
fit with a least squares regression for which the equations are shown.
(B) Scatter plot of slopes of the individual CO2 responses obtained for
each animal as well as the group means ± S.E.M. ∗P < 0.05. Horizontal
error bars in (A) indicate differences in the end-tidal PCO2 for individual
animals.
dose-dependent increase in respiratory motor output of anes-
thetized rats (Inyushkin et al., 2009; Inyushkina et al., 2010).
Inyushkina et al. (2010) attributed the respiratory stimulation, at
least in large part, to an inhibition of the reflex termination of
inspiration that results from the activation of vagal slowly adapt-
ing pulmonary stretch receptors (i.e., the Breuer–Hering inflation
reflex) as well as to an increase in the ventilatory response to
CO2 stimulation of central chemoreceptors (Inyushkina et al.,
2010). However, the current study demonstrates that modulation
of the Breuer–Hering reflexes is not required for the respira-
tory stimulation since the vagus nerves were sectioned bilat-
erally in the neck, thereby eliminating contributions from this
and other vagal reflexes. Additionally, the decreased effectiveness
of the Breuer–Hering reflexes described by Inyushkina et al.
(2010) could arise secondarily to the increased chemoreceptor
sensitivity rather than by a direct influence of leptin on the
Breuer–Hering reflex. In this regard, increasing PaCO2 has been
shown to reduce the effectiveness of the Breuer–Hering mod-
ulation of respiratory pattern by a mechanism that appears to
require input from carotid chemoreceptors (Mitchell et al., 1982;
Mitchell and Selby, 1987).
The second mechanism suggested by Inyushkina et al. (2010),
an increase in central CO2 chemoreceptor sensitivity, is consistent
with the tendency for the CO2 response curve to become steeper.
This is also consistent with the impaired ventilatory responses to
CO2 seen in leptin-deficient (ob/ob) mice and the recovery of that
response following leptin administration either intravenously or
into the fourth ventricle (Tankersley et al., 1996; O’Donnell et al.,
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FIGURE 4 | Mean arterial pressure and heart rate at baseline (0min) and at 15min intervals for the experiment in Figure 1 (leptin; n = 6 except as
indicated on graph; control, lactated Ringer’s; n = 4 except as indicated). Note the selective decrease in arterial pressure, ∗p < 0.05.
1999, 2000; Bassi et al., 2012). Whether a change in CO2 sensi-
tivity can fully explain the change in ventilation under baseline
ventilatory conditions will require further studies to identify the
relevant central and/or peripheral chemoreceptors: the key ques-
tion being whether any leptin-induced change in their discharge
can account for the change in phrenic discharge under baseline
conditions.
EFFECT OF SYSTEMIC LEPTIN INFUSION ON ARTERIAL PRESSURE
Leptin administered either systemically or centrally increases
sympathetic nerve activity to at least some target tissues (Dunbar
et al., 1997; Haynes et al., 1997), and, with chronic administra-
tion sufficient to mimic leptin levels seen in obesity, can lead
to increases in arterial pressure (Shek et al., 1998). However,
acute leptin administration has been reported to increase arterial
pressure only when it is administered centrally, an observation
explained at least in part by an offsetting increase in nitric oxide
production (Frühbeck, 1999; Beltowski et al., 2004). The mod-
erate decrease in arterial pressure in the current study occurred
in the absence of a change in heart rate, and is consistent with
the action of an additional factor, such as the production of nitric
oxide, that decreases the total peripheral resistance. However, the
dose of leptin used in the current study is similar to that used by
others who did not observe a decrease in arterial pressure (Haynes
et al., 1997; Frühbeck, 1999). The reason for the relatively greater
impact of a factor such as nitric oxide in the current study is
unclear and merits further investigation.
SUMMARY AND INTERPRETATION
Systemic administration of leptin led to a progressive increase
in the peak amplitude of phrenic nerve bursts. The time course
and pattern of the leptin-induced increase in phrenic motor
output is very similar to the pattern of plasticity (long-term
facilitation; Feldman et al., 2003) in phrenic nerve output that
follows either repeated brief periods of electrical stimulation of
the carotid sinus nerve or repeated brief exposures to hypoxia
(Feldman et al., 2003). Whether the phrenic response to leptin
is a form of plasticity depends on whether there is an increase
in leptin at the relevant receptors at the end of the 2 h record-
ing period, i.e., 60min after the end of leptin infusion. Hill
et al. (1998) have described the disappearance of leptin with 2
half-lives of 71 and 3.4min. The longer half-life is the result of
endogenous leptin binding to a plasma carrier molecule as well
as tissue binding sites. Injections of larger doses of exogenous
leptin would be expected to saturate these binding sites and the
unbound component would be subject to degradative mecha-
nisms that would result in the shorter (3.4min) half-life. On this
basis, our infused leptin would be expected to largely decline
to “physiological” levels after the end of the infusion period. It
should also be noted, that since leptin access to the brain is largely
via a receptor-mediated mechanism; access to the brain should
also be limited throughout the experiment. Nevertheless, if the
bound pool is sufficient to elicit the increase in phrenic nerve
discharge, longer follow-up times will be needed to determine
whether leptin induces plastic increases in the respiratory motor
output.
In behaving mammals, an increase in respiratory drive is
important for arterial blood gas homeostasis in the face of
a leptin-induced increase in energy expenditure (Morton and
Schwartz, 2011). In humans, a deficiency in leptin is rare, but
a subset of obese patients appears to develop “leptin resistance”
(Campo et al., 2007; Piper and Grunstein, 2011). Consistent with
animal studies, a subset of obese individuals have substantially
elevated circulating levels of leptin and exhibit a decreased respi-
ratory drive and CO2 sensitivity. They also have a high incidence
of obstructive sleep apnea and obesity hypoventilation syndrome.
The latter consists of daytime hypoventilation with hypercapnia
and hypoxemia (Piper and Grunstein, 2011). Interestingly, their
elevated leptin levels correlate better with hypercapnia than with
adiposity (Phipps et al., 2002). Reduced central concentrations of
leptin, due to defective leptin transport, or defects in the signal
transduction pathways activated by leptin could account for the
similarities between the respiratory profile of obese individuals
with leptin resistance and that of the ob/obmice.
Taken together with the earlier literature, these data suggest
that leptin has an important role in matching ventilation to the
www.frontiersin.org February 2013 | Volume 4 | Article 16 | 7
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metabolic requirements imposed by adipose tissue. The mecha-
nisms by which PaCO2 is maintained within narrow limits despite
marked changes in metabolism are largely a mystery. Our results
demonstrating leptin modulation of breathing begin to address
this question. Further elucidation will require identification of the
central pathways and molecular mechanisms by which activation
of central leptin receptors alters breathing.
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